Psychemedics Announces Addition Of FDA Cleared Drugs

Drug News, Press Releases

Psychemedics Corporation Logo

Psychemedics Adds Two FDA Cleared Drugs

World’s largest hair drug testing company & scientific leader launches new screening tests for Oxymorphone and D-Amphetamine/Adderall®.

ACTON, Mass., June 2, 2015 /PRNewswire/ — Psychemedics Corporation PMD, -0.06% hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to the company’s drug testing panels. In response to growing abuse concerns, the addition of Oxymorphone was made to the synthetic opiate testing panel and D-Amphetamine/Adderall® was added as an option to the Amphetamine panel.

Raymond C. Kubacki, Chairman, and CEO stated: “Sadly, more and more prescription drugs are being abused. As the scientific leader in drug testing, we at Psychemedics continue to advance the science and use our top-flight scientific team and R&D resources to develop new tests that will deter people from abusing these additional drugs.”

Oxymorphone (commonly known by the brand name Opana®) is an opioid prescription pain reliever that has a high potential for abuse, is approximately two times stronger than OxyContin®, and is reported by abusers to be a replacement for Oxycodone. Oxymorphone was placed on the Drug Alert Watch by the U.S. Department of Justice in 2011, as a growing nationwide threat because of the increase in abuse and overdoses. Psychemedics now includes this drug as part of its standard detection panel, at no additional charge to clients.

D-Amphetamine (most commonly known as Adderall®) is a prescription stimulant used for the medical treatment of ADHD and is classified as a Schedule II drug because of its highly addictive properties. Often sold and purchased illegally by recreational users for use as a performance enhancer, abusers are at risk for developing life-threatening addiction and/or psychological dependency. Psychemedics is currently the only hair testing laboratory that has the ability to test for this substance in its screening test. Adderall® now can be added as an option.

Jim Dyke, Vice President, Corporate Sales, and Marketing added: “The addition of Oxymorphone and Adderall® to our already expanded opiate panel will help us and our clients address head-on one of the major trends today – the continued and expanded abuse of prescription drugs.”

About Psychemedics CorporationPsychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.

https://www.marketwatch.com

Menu